Not FDA-Approved for General Wellness BPC-157, TB-500, KPV and GHK-Cu are not FDA-approved treatments for recovery, anti-aging, skin rejuvenation, digestive wellness or general wellness
far and above the rest
Six Phase I/II clinical trials enrolling approximately 900 participants confirmed an excellent safety profile with no serious adverse events attributed to the compound
These findings support a personalised approach, where absorption efficiency may be more relevant than absolute dosage
Practical Interpretation The mechanistic plausibility (NNMT NAD SIRT1/PGC-1 BMR & fat oxidation) is strong and consistent across preclinical models
Paul Daidone, MD, is an internal medicine physician and the medical director at True Self Recovery, an Arkansas-based substance abuse rehabilitation center